NCT03531814View on ClinicalTrials.gov

Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 23, 2018

Primary Completion Date

March 20, 2023

Study Completion Date

March 20, 2023

Conditions
Neurofibromatosis 1Neurofibroma, Plexiform
Interventions
BEHAVIORAL

Medication Event Monitoring System (MEMS^TM)

A computerized method of tracking the dates and times of a pill bottle being opened.

OTHER

Questionnaires

Adult and pediatric participants completed a series of questionnaires to assess medication adherence, demographics, life events, and barriers to adherence.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT03531814 - Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials | Biotech Hunter | Biotech Hunter